Verification evidence is still being completed.
PDF / print export
Novo Nordisk Kalundborg
Kalundborg, Denmark
- Verified lead
- Lars Fruergaard Jørgensen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and Chief Executive Officer
- 2026 technical specialization
- API Manufacturing, Biologics Processing, and Metabolic-Disease Supply
- Review cycle
- May 2026
- Full address
- Kalundborg, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Novo Nordisk management page confirming Lars Fruergaard Jørgensen as CEO.
- Editorial note
- Industrial-scale biologics manufacturing campus with large-format fermentation, fill-finish continuity, and global diabetes-supply significance.
API Manufacturing, Biologics Processing, and Metabolic-Disease Supply
GMP pharmaceutical manufacturing, Global quality systems
Industrial-scale biologics manufacturing campus with large-format fermentation, fill-finish continuity, and global diabetes-supply significance.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Kalundborg, Denmark
Novo Nordisk Kalundborg
API Manufacturing, Biologics Processing, and Metabolic-Disease Supply · Global commercial manufacturing
Industrial-scale biologics manufacturing campus with large-format fermentation, fill-finish continuity, and global diabetes-supply significance.
- Lead
- Lars Fruergaard Jørgensen (verified ↗)
- Address
- Kalundborg, Denmark (source ↗)
- Compliance
- GMP pharmaceutical manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global commercial manufacturing
- Capabilities
- API Production · Biologics Manufacturing · Large-Scale Process Operations
- Founded
- 1923
- Headcount
- 10000+
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Lars Fruergaard Jørgensen
President and Chief Executive Officer
Full addressKalundborg, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Novo Nordisk Kalundborg site page naming the production complex in Kalundborg.
Open sourceGlobal commercial manufacturing
Kalundborg, Denmark. API Manufacturing, Biologics Processing, and Metabolic-Disease Supply. Review completed on 14 Mar 2026.
Danish Medicines Agency and global pharmaceutical oversight
GMP pharmaceutical manufacturing, Global quality systems
API Manufacturing, Biologics Processing, and Metabolic-Disease Supply
Industrial-scale biologics manufacturing campus with large-format fermentation, fill-finish continuity, and global diabetes-supply significance.
Editorial note
Novo Nordisk adds heavyweight Danish industrial depth and a source-backed executive layer centered on the Kalundborg manufacturing complex.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
API Production
Biologics Manufacturing
Large-Scale Process Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Production utility networks
Biologics process suites
Analytical quality laboratories
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Novo Nordisk Kalundborg located?
- Novo Nordisk Kalundborg operates from Kalundborg, Denmark, Kalundborg, Denmark.
- Who runs Novo Nordisk Kalundborg?
- Novo Nordisk Kalundborg is led by Lars Fruergaard Jørgensen, President and Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Novo Nordisk Kalundborg hold?
- Novo Nordisk Kalundborg is documented under GMP pharmaceutical manufacturing.
- What does Novo Nordisk Kalundborg do?
- Industrial-scale biologics manufacturing campus with large-format fermentation, fill-finish continuity, and global diabetes-supply significance. Core capabilities: API Production, Biologics Manufacturing, Large-Scale Process Operations.
Editorial context
Related technical briefs
Briefs that name Kalundborg as a covered market or city.